Diaz PS - Search Results

1

The immunogenicity of the Oka/Merck varicella vaccine in relation to infectious varicella-zoster virus and relative viral antigen content.

Bergen RE, Diaz PS, Arvin AM. Bergen RE, et al. Among authors: diaz ps. J Infect Dis. 1990 Nov;162(5):1049-54. doi: 10.1093/infdis/162.5.1049. J Infect Dis. 1990. PMID: 2172393 Clinical Trial.

2

Equivalent recognition of a varicella-zoster virus immediate early protein (IE62) and glycoprotein I by cytotoxic T lymphocytes of either CD4+ or CD8+ phenotype.

Arvin AM, Sharp M, Smith S, Koropchak CM, Diaz PS, Kinchington P, Ruyechan W, Hay J. Arvin AM, et al. Among authors: diaz ps. J Immunol. 1991 Jan 1;146(1):257-64. J Immunol. 1991. PMID: 1670603

3

Lack of transmission of the live attenuated varicella vaccine virus to immunocompromised children after immunization of their siblings.

Diaz PS, Au D, Smith S, Amylon M, Link M, Smith S, Arvin AM. Diaz PS, et al. Pediatrics. 1991 Feb;87(2):166-70. Pediatrics. 1991. PMID: 1846236

4

The T-lymphocyte response to varicella-zoster viral proteins.

Arvin AM, Koropchak CM, Sharp M, Bergen R, Diaz PS. Arvin AM, et al. Among authors: diaz ps. Adv Exp Med Biol. 1990;278:71-81. doi: 10.1007/978-1-4684-5853-4_8. Adv Exp Med Biol. 1990. PMID: 1963047 No abstract available.

5

T lymphocyte cytotoxicity with natural varicella-zoster virus infection and after immunization with live attenuated varicella vaccine.

Diaz PS, Smith S, Hunter E, Arvin AM. Diaz PS, et al. J Immunol. 1989 Jan 15;142(2):636-41. J Immunol. 1989. PMID: 2536059

6

Investigation of varicella-zoster virus infection of lymphocytes by in situ hybridization.

Koropchak CM, Solem SM, Diaz PS, Arvin AM. Koropchak CM, et al. Among authors: diaz ps. J Virol. 1989 May;63(5):2392-5. doi: 10.1128/JVI.63.5.2392-2395.1989. J Virol. 1989. PMID: 2539528 Free PMC article.

7

Immunity to whole varicella-zoster virus antigen and glycoproteins I and p170: relation to the immunizing regimen of live attenuated varicella vaccine.

Diaz PS, Smith S, Hunter E, Arvin AM. Diaz PS, et al. J Infect Dis. 1988 Dec;158(6):1245-52. doi: 10.1093/infdis/158.6.1245. J Infect Dis. 1988. PMID: 2848901

8

Pharmacokinetics of acyclovir suspension in infants and children.

Sullender WM, Arvin AM, Diaz PS, Connor JD, Straube R, Dankner W, Levin MJ, Weller S, Blum MR, Chapman S. Sullender WM, et al. Among authors: diaz ps. Antimicrob Agents Chemother. 1987 Nov;31(11):1722-6. doi: 10.1128/AAC.31.11.1722. Antimicrob Agents Chemother. 1987. PMID: 2829714 Free PMC article.

9

Immunity to varicella-zoster viral glycoproteins, gp I (gp 90/58) and gp III (gp 118), and to a nonglycosylated protein, p 170.

Arvin AM, Kinney-Thomas E, Shriver K, Grose C, Koropchak CM, Scranton E, Wittek AE, Diaz PS. Arvin AM, et al. Among authors: diaz ps. J Immunol. 1986 Aug 15;137(4):1346-51. J Immunol. 1986. PMID: 3016094

10

Administration of oral acyclovir suppressive therapy after neonatal herpes simplex virus disease limited to the skin, eyes and mouth: results of a phase I/II trial.

Kimberlin D, Powell D, Gruber W, Diaz P, Arvin A, Kumar M, Jacobs R, Van Dyke R, Burchett S, Soong SJ, Lakeman A, Whitley R. Kimberlin D, et al. Pediatr Infect Dis J. 1996 Mar;15(3):247-54. doi: 10.1097/00006454-199603000-00014. Pediatr Infect Dis J. 1996. PMID: 8852914 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

40 results

Search Page

Filters